高级检索
当前位置: 首页 > 详情页

Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China [2]Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin 300020, China [3]Department of Ophthalmology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510120, Guangdong Province, China [4]Xiamen Kehong Eye Hospital, Xiamen 361000, Fujian Province, China
出处:
ISSN:

关键词: Anti-vascular endothelial growth factor Internal limiting membrane Macular edema Minimally invasive vitrectomy Proliferative diabetic retinopathy Vitreous macular traction

摘要:
AIM: To explore the efficacy of minimally invasive vitrectomy (MIV) with or without internal limiting membrane (ILM) peeling on the treatment of diabetic macular edema (DME) in proliferative diabetic retinopathy (PDR) combining with preoperative anti-vascular endothelial growth factor (anti-VEGF) injection. METHODS: Totally 132 eyes (132 patients) diagnosed PDR with DME were included between June 2015 and June 2018 in Tianjin Eye Hospital. The single MIV treatment group included 68 eyes and the MIV combined with ILM peeling group included 64 eyes. Anti-VEGF drugs were injected intravitreally 1wk before the operation and the period of follow-up was 1 to 3y. Best-corrected visual acuity (BCVA), central retinal thickness (CRT), total macular volume (TMV), macular edema (ME) severity, intraocular pressure (IOP), and complications were recorded. Prognostic factors of visual acuity following ILM peeling were analyzed. RESULTS: The BCVA was higher than preoperative values at 1, 3, 6, and 12mo after surgery in both groups (all P<0.05). At 6 and 12mo, the BCVA of the combined group was significantly higher than that of the MIV only group (0.52±0.23 vs 0.64±0.29 logMAR, P=0.011 in 6mo; 0.41±0.25 vs 0.52±0.25 logMAR, P=0.008 in 12mo). Mean CRT values postoperative were significantly lower than preoperative values in both groups from the 1st month (1mo 397.65±106.18 vs 451.94±118.88 μm in MIV only group; 388.88±108.68 vs 464.36±111.53 μm in combined group; both P<0.05) and decreased gradually. The differences between the two groups were statistically significant at 3, 6, and 12mo (P=0.004, 0.003, 0.00 respectively). The TMV was decreased from the 3rd month in the single treatment group (3mo 11.14±1.66 vs 12.20±2.09 mm3P<0.05). At 12mo, the proportion of eyes with edema that had CRT more than 350 μm was significantly lower than before surgery (13.24% vs 77.94% in MIV only group; 1.56% vs 81.25% in combined group; both P<0.05). There was no significant difference in the recurrence incidence of macular epiretinal membrane, ME, transient IOP increase, vitreous rebleeding, or traction retinal detachment between the two groups. BCVA after ILM excision was positively correlated with the CRT and ME degree before and after surgery (r=0.430, 0.485, respectively; P<0.05). CONCLUSION: MIV combined with ILM peeling accelerates the absorption of ME, improves vision, reduces the postoperative CRT and TMV, and reduces the recurrence rate of postoperative ME. © 2020 International Journal of Ophthalmology (c/o Editorial Office). All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 眼科学
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 眼科学
JCR分区:
出版当年[2018]版:
Q4 OPHTHALMOLOGY
最新[2023]版:
Q2 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China [3]Department of Ophthalmology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510120, Guangdong Province, China
共同第一作者:
通讯作者:
通讯机构: [1]Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China [2]Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin 300020, China [*1]Tianjin Eye Hospital, Clinical College of Ophthalmology, Tianjin Medical University.Tianjin Eye Institute, Tianjin Key Lab of Ophthalmology and Visual Science, No.4 Gansu Road, He-ping District, Tianjin 300020, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号